logo
Explore dividend stocks

Bioventix PLC

Add to watchlist
€46.8
Last updated:04/19/2021
51B: F
Bioventix PLC

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indi… Show more

Dividend yield
2.38%
€1.11 anually

3y growth is 5.48%

P/E ratio
30.91x
vs. 31.75x forward

Price is 30.91x times more than EPS €1.51 which eaquals €46.8

Payout ratio
73.63%
Yearly

73.63% of earnings is used as dividends.

CASH payout ratio

Last quarter

Become our supporter to unlock all data!
Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
Company debt level

Become our supporter to unlock all data!
51B dividends
Payout frequency
Unknown
Latest ex-date
04/08/2021
3y growth
5.48%
5y growth
Unknown
2021
€0.498
04/08/2021
£0.43
2020
Increase
€1.03
10/29/2020
£0.53
04/09/2020
£0.36
2019
€0.892
10/31/2019
£0.47
04/11/2019
£0.3
2018
€0.926
10/25/2018
£0.55
04/05/2018
£0.25
Company results
Quarterly
Annual
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
4.922289M
5.663347M
+15.06%
5.861663M
+3.50%
7.202697M
+22.88%
Cashflow
Sum up money going in and out company
3.956937M
5.922097M
+49.66%
5.877467M
-0.75%
7.682914M
+30.72%
Total liabilities
All combined debts and obligations
236.058K
864.657K
+266.29%
787.427K
-8.93%
778.868K
-1.09%
Company profile
CEO
Mr. Peter John Harrison MA
Market capitalization
Micro (245.93M)